Loading the section…
The price of Niagen Bioscience, Inc. (NAGE) on October 9, 2026 is 2.69 USD, +1.13% on the day. Over 52 weeks the stock traded between 2.61 USD and 7.95 USD; the price now sits 1% of the way up that range. Over the past year the price changed by -63.80%. The P/E ratio is 11.5, which is below the sector median (25.0). Market capitalization is 213.74 million USD, rank 7 among 11 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): −63.94 %
Niagen Bioscience, Inc. trades on Nasdaq under the ticker NAGE. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks NAGE has traded between 2.61 $ and 7.95 $. As of 9 October 2026 the price stood 1.50 % of the way from the 52-week low to the high.
Over one year NAGE shares fell 63.80 %; over six months they fell 40.22 %. Volatility over 90 days is 49.30 %. Dividends are not included: this is price change only, as of 9 October 2026.
NAGE trades at a price-to-earnings ratio of 11.5, below the sector median of 25.0. Price to sales is 1.6, below the sector median of 4.0. Price to book is 2.6, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 2.68 | 2.71 | 2.67 | 2.69 | 268,100 |
| 8 October 2026 | 2.71 | 2.71 | 2.61 | 2.66 | 635,100 |
| 7 October 2026 | 2.67 | 2.76 | 2.65 | 2.72 | 361,100 |
| 6 October 2026 | 2.67 | 2.71 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
No news about this security in English yet.
Address:10900 WILSHIRE BLVD SUITE 600, LOS ANGELES, CA, 90024, US
Niagen Bioscience, Inc. reported revenue of 130M $ and net income of 19M $ over the last four quarters. Net margin is 14.29 %. Revenue changed by +20.84 % year over year. Earnings per share are 0.21 $. Market capitalisation is 214M $.
NAGE has a return on equity of 22.64 %, above the sector median of −41.68 %. Return on assets is 16.30 %, above the sector median of −32.11 %. Operating margin is 10.03 %, above the sector median of −26.84 %.
| 16M |
| GLASGlass House Brands Inc. Subordinate Voting Shares | 4.26 | −3.40 % | 9M |
| AKANAkanda Corp. | 1.76 | −1.12 % | 5M |
| CRONCronos Group Inc. - Common Share | 3.23 | +0.31 % | 3M |
| USNAUSANA Health Sciences, Inc. | 14.66 | 0.00 % | 3M |
| 2.66 |
| 2.69 |
| 373,200 |
| 5 October 2026 | 2.79 | 2.79 | 2.67 | 2.68 | 864,800 |
| 2 October 2026 | 2.72 | 2.80 | 2.61 | 2.79 | 2M |
| 1 October 2026 | 2.91 | 2.92 | 2.67 | 2.68 | 1M |
| 30 September 2026 | 2.97 | 2.98 | 2.91 | 2.92 | 360,500 |
| 29 September 2026 | 3.00 | 3.00 | 2.95 | 2.95 | 279,100 |
| 28 September 2026 | 3.04 | 3.07 | 2.94 | 2.98 | 411,400 |
| 25 September 2026 | 3.02 | 3.06 | 2.98 | 3.05 | 618,900 |
| 24 September 2026 | 2.99 | 3.04 | 2.98 | 3.01 | 381,700 |
| 23 September 2026 | 3.08 | 3.09 | 3.00 | 3.00 | 390,900 |
| 22 September 2026 | 3.08 | 3.12 | 3.04 | 3.09 | 476,800 |
| 21 September 2026 | 2.99 | 3.04 | 2.97 | 3.04 | 292,100 |
| 18 September 2026 | 2.99 | 3.03 | 2.97 | 2.99 | 609,200 |
| 17 September 2026 | 2.99 | 3.04 | 2.98 | 2.99 | 217,200 |
| 16 September 2026 | 3.01 | 3.05 | 2.98 | 3.00 | 340,200 |
| 15 September 2026 | 3.04 | 3.04 | 2.95 | 3.00 | 573,500 |
| 14 September 2026 | 3.04 | 3.10 | 3.03 | 3.04 | 420,700 |